Prolonged ozone exposure in an allergic airway disease model: Adaptation of airway responsiveness and airway remodeling
© Jang et al. 2006
Received: 30 September 2005
Accepted: 13 February 2006
Published: 13 February 2006
Short-term exposure to high concentrations of ozone has been shown to increase airway hyper-responsiveness (AHR). Because the changes in AHR and airway inflammation and structure after chronic ozone exposure need to be determined, the goal of this study was to investigate these effects in a murine model of allergic airway disease.
We exposed BALB/c mice to 2 ppm ozone for 4, 8, and 12 weeks. We measured the enhanced pause (Penh) to methacholine and performed cell differentials in bronchoalveolar lavage fluid. We quantified the levels of IL-4 and IFN-γ in the supernatants of the bronchoalveolar lavage fluids using enzyme immunoassays, and examined the airway architecture under light and electron microscopy.
The groups exposed to ozone for 4, 8, and 12 weeks demonstrated decreased Penh at methacholine concentrations of 12.5, 25, and 50 mg/ml, with a dose-response curve to the right of that for the filtered-air group. Neutrophils and eosinophils increased in the group exposed to ozone for 4 weeks compared to those in the filtered-air group. The ratio of IL-4 to INF-γ increased significantly after exposure to ozone for 8 and 12 weeks compared to the ratio for the filtered-air group. The numbers of goblet cells, myofibroblasts, and smooth muscle cells showed time-dependent increases in lung tissue sections from the groups exposed to ozone for 4, 8, and 12 weeks.
These findings demonstrate that the increase in AHR associated with the allergic airway does not persist during chronic ozone exposure, indicating that airway remodeling and adaptation following repeated exposure to air pollutants can provide protection against AHR.
Asthma is characterized by the presence of a variable airflow limitation, airway hyper-responsiveness (AHR), and airway inflammation . Acute exposure to ozone, which is an important component of the photochemical oxidation products of substrates emitted as air pollution from automobile engines , decreases pulmonary function, increases AHR, and induces airway inflammation in dogs , guinea pigs , and humans [5–7]. Chronic airway inflammation is associated with airway remodeling that includes airway wall thickening as a result of inflammatory and structural changes, such as edema; inflammatory cell infiltration; mucous gland hyperplasia; reticular basement membrane thickening; subepithelial fibrosis; vascular smooth muscle cell proliferation, hyperplasia, and hypertrophy; and myofibroblast and goblet cell hypertrophy [8–11]. Airway wall thickening and airway reactivity were inversely associated in patients with asthma, suggesting that airway wall thickening prevents excessive airway narrowing in human subjects in vivo .
Interleukin (IL)-4 is key factor contributing to the chronic inflammatory state that characterizes asthma and may be involved in the connective tissue alterations that characterize airway remodeling in asthma. IL-4 can stimulate fibroblasts . Interferon (IFN)-γ, thought to be deficient in asthma, can antagonize some of the effects of IL-4 .
The effects of long-term, repeated exposure to ozone on AHR and airway structural changes remain poorly defined. Our underlying hypothesis is that repeated episodes of ozone exposure give rise to some of the remodeling changes associated with asthma, which may in turn be associated with sustained airway dysfunction. The aims of this study were to examine the relationship between ozone exposure and AHR by using barometric whole-body plethysmography (WBP) and to characterize the airway structural changes following a daily 8-h exposure to 2 ppm ozone for 4, 8, and 12 weeks in a murine model of asthma. Airway inflammation was also assessed by analysis of bronchoalveolar lavage (BAL) fluid.
Female BALB/c mice (aged 5 to 6 weeks; DaeMul Laboratories, Daejeon, Korea) known to be high IgE responders were used. The mice were maintained on an ovalbumin (OVA)-free diet and were individually housed in rack-mounted stainless steel cages with free access to food and water.
Ovalbumin-induced allergic airway disease model
An OVA-induced allergic airway disease model of asthma was used with some modification . Briefly, mice were sensitized on days 1 and 14 by intraperitoneal injection with 10 μg of grade V OVA (Sigma Chemicals, St. Louis, MO) and 1 mg of aluminum potassium sulfate (Sigma Chemicals) in 500 μL of saline solution. On days 21 to 23, the mice were challenged by daily exposure (30 min) to an aerosol of 1% (wt/vol) OVA in saline solution. Vehicle control mice were treated with a suspension of aluminum potassium sulfate (1 mg) in saline solution (500 μL) and challenged with aerosolized saline solution daily from days 21 to 23. Aerosol challenge was conducted on groups of up to 12 mice in a closed chamber attached to an ultrasonic nebulizer (NE-UO7; Omron Corporation, Tokyo, Japan) with an output of 1 mL/min and 1- to 5-μm particle size.
Determination of airway responsiveness
Airway responsiveness was measured by barometric plethysmography using whole-body plethysmography (WBP; Buxco, Troy, NY) after ozone exposure, while the animals were awake and breathing spontaneously as a modification of the method described by Hamelmann et al. . Enhanced pause (Penh) to methacholine as measured using barometric plethysmography is a valid indicator of bronchoconstriction in mice and can be used to measure AHR [17–19]. Aerosolized methacholine in increasing concentrations (2.5–50 mg/ml) was nebulized through an inlet of the main chamber for 3 min.
Bronchoconstriction alters breathing patterns, and changes in the timing of early and late expirations (Pause) and in Penh are the results of alterations in the timing of breathing, as well as the prolongation of the expiratory time. Furthermore, airway constriction increases the thoracic flow asynchronously with the nasal flow, resulting in an increase in the box pressure signal. Penh is an empiric parameter that reflects changes in the waveform of the measured box pressure signal that are a consequence of bronchoconstriction. Before taking readings, the box was calibrated with a rapid injection of 150 μl of air into the main chamber. The difference between the pressure in the main chamber of the WBP containing the animal and that in a reference chamber was measured as the box pressure signal, which is caused by the pressure change in the main chamber during the respiratory cycle of the animal. A pneumotachograph with defined resistance in the wall of the main chamber acted as a low-pass filter and allowed thermal compensation. The time constant of the box was determined to be approximately 0.02 s. Mice were placed in the main chamber, and baseline readings were taken and averaged for 3 min.
BAL fluid preparation and analysis
BAL was performed immediately after the last measurement of airway responsiveness. The mice were deeply anesthetized with 50 mg/kg of pentobarbital sodium injected intraperitoneally and were killed by exanguination from the abdominal aorta. The trachea was cannulated with a polyethylene tube through which the lungs were lavaged three times with 1.0 ml of physiological saline (4.0 ml total fluid removed). The BAL fluid was filtered through wet gauze (4 × 4 inches). Trypan blue exclusion for viability and total cell count was performed. The BAL fluid was centrifuged at 150 × g for 10 min. The obtained pellet was immediately suspended in 4 ml of physiological saline, and total cell numbers in the BAL fluid were counted in duplicate with a hemocytometer (improved Neubauer counting chamber). A 100-μl aliquot was centrifuged in a cytocentrifuge (model 2 Cytospin; Shandon Scientific Co., Pittsburg, PA), and differential cell counts were performed using the centrifuged preparations stained with Diff-quick, counting 500 or more cells for each animal at a magnification of ×1000 (oil immersion).
The levels of IL-4 and IFN-γ were quantified in the supernatants of BAL fluids by enzyme immunoassays according to the manufacturer's protocol (Endogen Inc., Woburn, MA). The sensitivity of the assays was 5 pg/ml.
Preparation of lung tissues and morphological analysis
The mice were euthanized after the final exposure, and the lungs and trachea were filled intratracheally with a fixative (0.8% formalin, 4% acetic acid) using a ligature around the trachea. The lungs were removed, and lung tissues were fixed with 10% (vol/vol) neutral buffered formalin. The specimens were dehydrated and embedded in paraffin. For histological examination, 4-μm sections of fixed, embedded tissues were cut on a Leica model 2165 rotary microtome (Leica Microsystems, Nussloch, Germany), placed on glass slides, deparaffinized, and stained sequentially with toluidine blue (Richard-Allan Scientific, Kalamazoo, MI). Selected toluidine blue-stained sections were used for measuring epithelial, goblet, and smooth muscle cells providing that the epithelium and submucosa could be easily identified and that the number of epithelial, goblet, and smooth muscle was adequate to allow multiple measurements (i.e., approximately 1 mm). Areas of the lung tissue with intact surface epithelium were selected for examination and quantification under a transmission electron microscope (H-7000; Hitachi, Tokyo, Japan). Ultrathin sections were cut, placed on high-transmission, 200-mesh, thin-bar copper grids, and stained with uranyl acetate and lead citrate. Light microscopic quantification was performed at ×200, and electron microscopy was performed at ×5000.
The cells that were counted (e.g., myofibroblasts) were used as evidence of airway remodeling rather than inflammation in a subepithelial zone of the entire transmission electron microscopy section, and the counts were expressed per 0.1 mm2 of tissue. Myofibroblasts were identified by spindle-like projections, dilated rough endoplasmic reticulum, a greatly infolded and crenated nuclear membrane, and bundles of parallel cytoplasmic filaments associated with dense body condensations. The sections were coded and examined under light microscopy in random order by the same observer, who was unaware of the origin of the sections. Intra-observer repeatability was assessed by measuring the same section four times and was expressed as a percentage of the coefficient of variation for the four measurements.
All data were analyzed using SPSS version 7.5 for Windows (SPSS Inc., Chicago, IL). The data are expressed as means ± SE. For measured variables with a normal distribution, Student's paired t-test was used to compare paired data. For variables that did not have a normal distribution, the Mann-Whitney U-test was used for comparisons. Differences with p-values less than 5% were regarded as statistically significant.
The proportions of eosinophils and neutrophils in BAL fluids were significantly higher in the group exposed to ozone for 4 weeks than in the filtered-air group (filtered-air group vs. ozone-exposed for 4 vs. 8 vs. 12 weeks: eosinophils, 1.5 ± 0.28 vs. 2.5 ± 0.13 vs. 1.11 ± 0.05 vs. 1.8 ± 0.08%; neutrophils, 2.2 ± 1.32 vs. 4.5 ± 1.02 vs. 1.9 ± 1.22 vs. 2.5 ± 2.01%, respectively; p < 0.05).
The INF-γ level decreased significantly after 4, 8, and 12 weeks of ozone exposure compared to that of the filtered-air group. The IL-4 level in BAL fluids was not different between any of the ozone-exposed groups and the filtered-air group (filtered-air group vs. ozone-exposed for 4 vs. 8 vs. 12 weeks: IFN-γ, 75.4 ± 2.57 vs. 30.3 ± 9.52 vs. 64.9 ± 2.9 vs. 55.6 ± 6.64 pg/ml; IL-4, 33.3 ± 3.27 vs. 65.1 ± 2.96 vs. 55.6 ± 6.64 vs. 45.9 ± 5.26 pg/ml, respectively). The ratio of IL-4 to INF-γ increased significantly after 4, 8, and 12 weeks of ozone exposure compared to the ratio of the filtered-air group (filtered-air group vs. ozone-exposed for 4 vs. 8 vs. 12 weeks: 0.43 ± 0.1 vs. 3.24 ± 3.4 vs. 1.30 ± 0.89 vs. 0.96 ± 0.38, respectively; p < 0.05). The ozone-exposed groups also demonstrated significantly increased protein levels compared to that of the filtered-air group (filtered-air group vs. ozone-exposed for 4 vs. 8 vs. 12 weeks: 10.07 ± 0.06 vs. 14.55 ± 0.76 vs. 11.12 ± 0.03 vs. 12.05 ± 0.11 μg/μl; p < 0.01).
We examined the effects of long-term exposure to ozone on airway remodeling and dysfunction in a mouse model of allergic airway disease. By measuring airway responses to methacholine, we found a decrease in AHR after long-term ozone exposure. We also observed collagen deposition and smooth muscle cell hyperplasia and hypertrophy in mice subjected to long-term ozone exposure. These changes suggest that chronic airway remodeling may be associated with AHR and airway inflammation following long-term exposure to ozone.
Chronic but not brief allergen exposure was associated with a markedly increased amount of extracellular matrix in the subepithelial region of the airway wall and with increased mucin content within the airway epithelium at 4 and 8 weeks after the last allergen challenge . Repeated inflammatory events may contribute to airway remodeling in asthma . Animal studies of allergen-induced AHR have shown that prolonged OVA exposure results in the increased deposition of fibronectin and collagen, which was accompanied by a progressive decrease in AHR, indicating that thickening or stiffening of the airway may be protective against AHR [22, 23]. The increase in goblet cell number and in mucus lining the airway may serve a protective function against inhaled toxins and excessive mucosal dehydration .
We measured lung function using unrestrained plethysmography, which in conscious mice represents the extreme of noninvasiveness and is highly convenient; however, it provides respiratory measurements that are so tenuously linked to respiratory mechanics that they cannot be considered as meaningful indicators of lung function . In our study using a murine model of asthma, the increase in AHR following OVA sensitization and challenge decreased after repeated exposure to ozone over a period of up to 12 weeks, indicating that structural airway changes can occur as protection against AHR after repeated exposure to air pollutants. Such changes included goblet cell hyperplasia, increased myofibroblast proliferation, increased collagen deposition, and smooth muscle hypertrophy and hyperplasia. Many asthma patients present evidence of residual airway obstruction, which can exist in asymptomatic patients, after antiasthma drugs; this probably represents remodeling. Remodeling may also be important in the pathogenesis of nonspecific AHR, especially the component that reverses slowly or incompletely with inhaled glucocorticosteroid treatment .
Airway injury or inflammation caused by air pollutants has been evaluated mainly by the analysis of fluids collected by bronchoalveolar lavage, which is an especially invasive technique totally unsuitable for children. Research in the field of biomarkers is providing new perspectives with the development of noninvasive tests for monitoring inflammation and damage in the deep lung. Our data in a murine model of asthma suggest that repeated exposure to air pollutants can induce airway remodeling and may account for irreversible airway obstruction.
It is necessary to speculate on how various aspects of the remodeling process could contribute to airway dysfunction and nonspecific AHR. IL-4 produced by several cell types, predominantly by Th2 lymphocytes, is believed to contribute to the characteristic inflammatory response in asthmatic airways . IL-4 can modulate the behavior of fibroblasts  and may stimulate fibroblast-mediated contraction of extracellular matrix, as in a model of the tissue remodeling characteristics of fibrotic lesions . The Th2-derived cytokines, IL-4 and IL-13, can stimulate the production of TGF-β in airway epithelial cells but not in lung fibroblasts. IFN-γ, in contrast, can inhibit TGF-β2 release both under basal conditions and following IL-4 or IL-13 stimulation. The ability of these cytokines to modulate TGF-β release may contribute to both normal airway repair and the development of subepithelial fibrosis in asthma . In the present study, the decrease in INF-γ, the trend toward an increase in IL-4, and the increase in the ratio of IL-4 to INF-γ after chronic ozone exposure may contribute to structural airway changes following repeated ozone exposure in a murine model of asthma. Further studies are needed to clarify the potential mechanisms responsible for the AHR decrease in ozone-exposed mice despite the increase in airway smooth muscle mass and airway inflammation, as shown in the present study.
In conclusion, we have demonstrated that the airway physiology and airway structure are altered in a murine model of asthma chronically exposed to ozone. Sustained airway dysfunction was observed after 4 weeks of ozone exposure, and airway remodeling was sustained following 12 weeks of ozone exposure. The observation that airway remodeling persists after the recovery of AHR supports the postulate that structural changes contribute to changes of AHR in mice chronically exposed to ozone.
This work was supported by grant R01-2003-000-0041-0 From the Basic Research Program of the Korea Science & Engineering Foundation
- Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001, 344:350–362.View ArticlePubMedGoogle Scholar
- Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society: Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996, 153:3–50.View ArticleGoogle Scholar
- Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H, Walters EH, Alpert SE, Nadel JA: Importance of airway inflammation for hyperresponsiveness induced by ozone in dogs. Am Rev Respir Dis 1983, 127:686–690.PubMedGoogle Scholar
- Murlas CG, Roum JH: Sequence of pathologic changes in the airway mucosa of guinea pigs during ozone-induced bronchial hyperreactivity. Am Rev Respir Dis 1985, 131:314–20.PubMedGoogle Scholar
- Basha MA, Gross KB, Gwizdala CJ, Haidar AH, Popovich J: Bronchoalveolar lavage neutrophilia in asthmatic and healthy volunteers after controlled exposure to ozone and filtered purified air. Chest 1994, 106:1757–1765.View ArticlePubMedGoogle Scholar
- Seltzer J, Bigby BG, Stulbarg M, Holtzman MJ, Nadel JA, Ueki IF, Leikauf GD, Goetzl EJ, Boushey HA: O3-induced change in bronchial reactivity to methacholine and airway inflammation in humans. J Appl Physiol 1986, 60:1321–1326.PubMedGoogle Scholar
- Koren HS, Devlin RB, Graham DE, Mann R, McGee MP, Horstman DH, Kozumbo WJ, Becker S, House DE, McDonnell WF: Ozone-induced inflammation in the lower airways of human subjects. Am Rev Respir Dis 1989, 139:407–415.View ArticlePubMedGoogle Scholar
- Jeffery PK: Remodelling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001, 164:s28-s38.View ArticlePubMedGoogle Scholar
- Beckett PA, Howarth PH: Pharmacotherapy and airway remodeling in asthma? Thorax 2003, 58:163–174.View ArticlePubMedPubMed CentralGoogle Scholar
- Elias JA, Zhu Z, Chupp G, Homer RJ: Airway remodeling in asthma. J Clin Invest 1999, 104:1001–1006.View ArticlePubMedPubMed CentralGoogle Scholar
- Roche WR, Beasley R, Williams JH, Holgate ST: Subepthelial fibrosis in the bronchi of asthmatics. Lancet 1989, 1:520–524.View ArticlePubMedGoogle Scholar
- Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M: Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 2003, 168:983–988.View ArticlePubMedGoogle Scholar
- Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B: Interleukin (IL)-4 and IL013 act on human lung fibroblasts. J Clin Invest 1998, 101:2129–2139.View ArticlePubMedPubMed CentralGoogle Scholar
- Cohn L, Herrick C, Niu N, Homer R, Bottomly K: IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN gamma in the regulation of allergic airway inflammation. J Immunol 2000, 166:2760–2767.View ArticleGoogle Scholar
- Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H: Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994, 24:73–80.View ArticlePubMedGoogle Scholar
- Jang AS, Choi IS, Kim SW, Song BC, Yeum CH, Jung JY: Airway obstruction after acute ozone exposure in BALB/c mice using barometric plethysmography. Kor J Intern Med 2003, 18:1–5.View ArticleGoogle Scholar
- Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997, 156:766–775.View ArticlePubMedGoogle Scholar
- Johanson WG Jr, Pierce AK: A noninvasive technique for measurement of airway conductance in small animals. J Appl Physiol 1971, 30:146–150.PubMedGoogle Scholar
- Pennock BE, Cox CP, Rogers RM, Cain WA, Wells JH: A noninvasive technique for measurement of changes in specific airway resistance. J Appl Physiol 1979, 46:399–406.PubMedGoogle Scholar
- Leigh R, Ellia R, Wattie J, Southam DS, de Hoogh M, Gauldie J, O'Byrne PM, Inman MD: Dysfunction and remodeling of the mouse airway persist agter resolution of acute allergen-induced airway inflammation. Am J Respir Crit Care Med 2002, 27:526–535.Google Scholar
- Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK: An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolized allergen. Thorax 1998, 53:849–856.View ArticlePubMedPubMed CentralGoogle Scholar
- Palmans E, Kips JC, Pauwels RA: Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000, 161:627–635.View ArticlePubMedGoogle Scholar
- Vanacker NJ, Palmans E, Pauwels RA, Kips JC: Fluticasone inhibits the progression of allergen-induced structural airway changes. Clin Exp Allergy 2002, 32:914–920.View ArticlePubMedGoogle Scholar
- McParland BE, Macklem PT, Pare PD: Airway hyperresponsiveness: From molecules to bedside invited review: airway wall remodeling: friend or foe? J Appl Physiol 2003, 95:426–434.View ArticlePubMedGoogle Scholar
- Bates JH, Irvin CG: Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 2003, 94:1297–1306.View ArticlePubMedGoogle Scholar
- Kips JA, Pauwels RA: Airway wall remodeling: does it occur and what does it mean? Clin Exp Allergy 1999, 29:1457–1466.View ArticlePubMedGoogle Scholar
- Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787–793.View ArticlePubMedGoogle Scholar
- Postlethwaite AE, Seyer JM: Fibroblast chemotaxis induction by human recombinant interleukin-4. J Clin Invest 1991, 87:2147–2152.View ArticlePubMedPubMed CentralGoogle Scholar
- Wen FQ, Kohyama T, Liu X, Zhu YK, Wang H, Kim HJ, Kobayashi T, Abe S, Spurzem JR, Rennard SI: Interleukin-4 and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 2002, 26:484–490.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.